-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

636. Myelodysplastic Syndromes—Basic and Translational Studies: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 3, 2018: 6:00 PM-8:00 PM
Hall GH (San Diego Convention Center)

Andrew E Menssen, BA1, Christopher A Miller, PhD2*, Ajay J Khanna2*, Gue Su Chang, PhD3*, Jin J Shao2*, Sridhar Nonavinkere Srivatsan, MS2*, Joshua Robinson2*, Kimberly J Brendel2*, Sharon E Heath4*, Eric J. Duncavage, MD5 and Matthew J. Walter, MD6

1Division of Oncology, Washington University School of Medicine, University City, MO
2Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
3Division of Oncology, Washington University School of Medicine, St Louis, MO
4Washington University School of Medicine, St. Louis, MO
5Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO
6Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Tzu Hua Chen-Liang1*, Ana M Hurtado López2*, Laura Palomo, MSc3*, Teresa Bernal Del Castillo, MD, PhD4*, Mar Tormo5*, Maria Lourdes Hermosin, MD6*, María-José Jimenez7*, Navarro Blanca8*, Esperanza Such9*, Rafael Andres DEL Orbe Barreto10*, Nuria de Haro11*, Félix López Cadenas, MD12*, Begoña Muiña13*, Raquel de Oña14*, Carmen Benet15*, Eduardo José Salido, MD16*, Raul Teruel-Montoya17*, Fernando Ramos18*, Leonor Senent19*, Maria Díez-Campelo20*, Beatriz Arrizabalaga, MD. PhD21*, Blanca Xicoy22*, Francisco José Ortuño17*, Francesc Solé, PhD23*, Guillermo Sanz, MD, PhD24 and Andres Jerez25*

1Hematology and Medical Oncology Department, Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, MURCIA, Murcia, Spain
2Hematology and Medical Oncology Department, Hospital Morales Meseguer, Universidad de Murcia, Murcia, Spain
3MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
4Hospital Universitario Central de Asturias, Oviedo, Spain
5Hematology Department, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia, Valencia, Spain
6Jerez de la Frontera Hospital, JEREZ DE LA FRONTERA, Spain
7Hematology Department, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain
8Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Valencia, Valencia, Spain
9Servicio de Hematología. Hospital La Fe, Valencia, Spain, Valencia, Spain
10Edif. Laboratorios, planta baja., Hospital Universitario Cruces Servicio de Hematología. Sección Eritropatología – Hem. Molecular, Barakaldo, Spain
11Josep Carreras Leukaemia- Research Institute, ICO-Hospital Germans Trias i Pujol,, Badalona, Spain
12Departamento de Hematología, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
13Hematology Unit.Hospital Rafael Méndez, Lorca, Spain
14MD Anderson Cancer Center, Madrid, Spain
15Hospital Arnau de Vilanova, Valencia, Spain
16Department of Hematology, Virgen de la Arrixaca University Hospital, IMIB, Murcia, Murcia, ESP
17Hematology and Medical Oncology Department, Hospital Morales Meseguer, Universidad de Murcia, IMIB, Murcia, Spain
18Instituto de Biomedicina (IBIOMED), Hospital Universitario de León, Léon, Spain
19Hematology Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain
20Hematology department, Hospital Clinico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
21Department of Hematology, Hospital Universitario Cruces, Vizcaya, Spain
22Hematology Service, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Spain
23MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Badalona, Spain
24Hematology Department, Hospital Universitario La Fe, Valencia, Spain
25Hematology and Medical Oncology Department, IMIB, Hospital Morales Meseguer. Centro Regional de Hemodonación, Universidad de Murcia, Murcia, Spain

Ana M Hurtado López1*, Tzu Hua Chen-Liang2*, Joaquín Panadero3*, Eduardo José Salido, MD4*, Victor Beltrán5*, Begoña Muiña6*, Noelia Navarro-Villamor7*, Inés Calabria3*, Ana Isabel Antón7*, Francisco José Ortuño8*, Vicente Vicente, MD. PhD9* and Andres Jerez10*

1Hematology and Medical Oncology Department, Hospital Morales Meseguer, Universidad de Murcia, Murcia, Spain
2Hematology and Medical Oncology Department, Hospital Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB, MURCIA, Murcia, Spain
3Genomics Unit, Health Research Institute La Fe, Valencia, Spain
4Department of Hematology, Virgen de la Arrixaca University Hospital, IMIB, Murcia, Murcia, ESP
5Hematology Unit. H Virgen del Castillo. Yecla, Yecla, Spain
6Hematology Unit.Hospital Rafael Méndez, Lorca, Spain
7Genomics Unit. IMIB-Arrixaca, Murcia, Murcia, Spain
8Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, murcia, Spain
9Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, Murcia, Spain
10Hematology and Medical Oncology Department, IMIB, Hospital Morales Meseguer. Centro Regional de Hemodonación, Universidad de Murcia, Murcia, Spain

Masataka Taguchi1*, Hiroyuki Mishima, DDS, Ph.D.2*, Yusuke Shiozawa, M.D., Ph.D.3*, Chisa Hayashida2*, Akira Kinoshita, Ph.D.2*, Shinya Sato, M.D., Ph.D.1*, Makiko Horai, M.D., Ph.D.1*, Masatoshi Matsuo, M.D., Ph.D.1*, Hidehiro Itonaga, M.D., Ph.D.1*, Takeharu Kato, M.D., Ph.D.1*, Hiroaki Taniguchi, M.D., Ph.D.4*, Daisuke Imanishi, M.D., Ph.D.1*, Yoshitaka Imaizumi, M.D., Ph.D.1*, Tomoko Hata, M.D., Ph.D.1*, Motoi Takenaka, M.D., Ph.D.5*, Hideki Makishima, MD, PhD6, Yasuhito Nannya, MD, PhD3, Yukiyoshi Moriuchi, M.D.4*, Seishi Ogawa, MD, PhD7, Koh-ichiro Yoshiura, M.D., Ph.D.2* and Yasushi Miyazaki, MD, PhD1

1Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
2Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
3Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
5Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
6Department of Pathology and Tumor Biology,Graduate School of Medicine, Kyoto University,Japan, Kyoto, Japan
7Department of Pathology and Tumor Biology, Kyoto University, Graduate School of Medicine, Kyoto, Japan

Christopher Felix Krombholz, PhD1*, Lorena Gallego Villar, PhD1*, Pritam Kumar Panda, MSc, MS, BSc1*, Sushree Sangita Sahoo, MSc1*, Marcin W. Wlodarski, MD, PhD2,3, Daniel B. Lipka4*, Christoph Plass3,5*, Charlotte Niemeyer, MD3,6*, Miriam Erlacher, MD, PhD1,3* and Christian Flotho1,3*

1Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Hematology, St. Jude Children's Research Hospital, Memphis, TN
3German Cancer Consortium (DKTK), Heidelberg, Germany
4Regulation of Cellular Differentiation Group, Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany
5Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany
6Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany

Janghee Woo, MD, PhD1,2,3, Sandra Stehling-Sun, PhD2*, H. Joachim Deeg, MD1,3, Thalia Papayannopoulou, MD, DrSci4, Fyodor D Urnov, PhD2* and John A Stamatoyannopoulos, MD2,3,5*

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Altius Institute for Biomedical Sciences, Seattle, WA
3Division of Oncology, Department of Medicine, University of Washington, Seattle, WA
4Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
5Department of Genome Sciences, University of Washington, Seattle, WA

Abhishek A. Mangaonkar, MD1, Kaaren K. Reichard, MD2*, April Chiu, MD3*, Matthew T Howard, MD4*, Rebecca L King, MD5, Ryan M. Carr, M.D., Ph.D.1*, Bonnie M Alver6*, Keith D. Robertson7*, Margot Cousin, PhD8*, Jose C Villasboas9*, Martin E. Fernandez-Zapico, MD10*, Terra L. Lasho, PhD1, Naseema Gangat, MBBS1, Aref Al-Kali, MD11, Michelle A. Elliott, MD1, William J. Hogan, MBBCh12, Mark R. Litzow, MD1, Animesh Pardanani, MBBS, PhD 1, Eric Solary, MD, PhD13, Ayalew Tefferi, MD1 and Mrinal M. Patnaik, MD, MBBS1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester, MN
4Division of Hematopathology, Mayo Clinic, Rochester, MN
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester
7Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN
8Department of Health Sciences Research, Center for Individualized Medicine, Mayo Clinic, Rochester, MN
9Division of Hematology, Human Immune Monitoring Core, Mayo Clinic, Rochester, MN
10Department of Oncology, Mayo Clinic, Rochester, MN
11Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, MN
12Division of Hematology, Mayo Clinic, Department of Internal Medicine, Division of Hematology, Rochester, MN
13Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France

Yihong Guan1*, Anand D. Tiwari, PhD.1*, Metis Hasipek, PhD2*, Dale Grabowski, BS2*, Yvonne Parker2*, Cassandra M. Hirsch2*, Amy C Graham, BS, MS2*, Yasunobu Nagata2*, Bartlomiej P. Przychodzen1*, Aziz Nazha, MD2, Daniel Lindner, MD, PhD2*, Tomas Radivoyevitch, PhD2,3*, James G Phillips, PhD2*, Jaroslaw P. Maciejewski2 and Babal K. Jha1*

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
3Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

Yihong Guan1*, Edward F Greenberg, MD1, Metis Hasipek, PhD1*, Cassandra M. Hirsch1*, Amy C Graham, BS, MS1*, Tomas Radivoyevitch, PhD1,2*, Shi Chen3*, Xiaochen Liu3*, Valeria Visconte, PhD4, Dewen You, PhD1*, Eiju Negoro, MD, PhD1*, Bartlomiej P. Przychodzen5*, Hideki Makishima, MD, PhD1,6, Aziz Nazha, MD1, Daniel Gackowski, PhD7*, Ewelina Zarakowska7*, Mridul Mukherji, D.Phil.8*, Mikkael A. Sekeres, MD, MS1, Mingjiang Xu, MD, PhD3, Ryszard Ólinski, Professor7*, Jaroslaw P. Maciejewski1 and Babal K. Jha1*

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
3Department of Biochemistry and Molecular Biology & Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Taussig Cancer Institute, Cleveland, OH
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
7Department of Clinical Biochemistry, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
8School of Pharmacy, University of Missouri - Kansas City, Kansas City, MO

Matilde Y Follo, PhD1*, Andrea Pellagatti, PhD2*, Richard N Armstrong, PhD2*, Stefano Ratti, MD1*, Sara Mongiorgi, PhD1*, Annalisa Astolfi, PhD3*, Valentina Indio, PhD3*, Maria Teresa Bochicchio4*, Cristina Clissa, MD, PhD5,6*, Domenico Russo, MD7, Marco Gobbi, MD8*, Sarah Parisi6, Miriam Fogli, PhD9*, Giovanni Martinelli6, Andrea Pession, MD10*, Michele Cavo, MD6*, Lucia Manzoli, MD1*, Lucio Cocco, MD1*, Jacqueline Boultwood, PhD2 and Carlo Finelli, MD11*

1Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
2Bloodwise Molecular Haematology Unit, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
3Interdepartmental Centre of Cancer Research "G. Prodi", University of Bologna, Bologna, Italy
4Institute of Hematology "L. and A. Seràgnoli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
5Hematology and Stem Cell Transplant Center, AORMN, Pesaro, Italy
6Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, "S. Orsola-Malpighi" Hospital, Bologna, Italy
7Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, Chair of Hematology, Dpt of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
8Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
9Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", S.Orsola-Malpighi University Hospital, Bologna, Italy
10Sant'Orsola-Malpighi Hospital, "Lalla Seràgnoli" Institute, Bologna, Italy
11Department of Oncology and Hematology, S. Orsola-Malpighi University Hospital, Bologna, Italy

Angel Y.F. Kam, PhD1*, Sadhna O. Piryani, BS1*, Chad M. McCall, MD, PhD2*, Hee Su Park1*, Nelson J. Chao, MD1 and Phuong L. Doan, MD1

1Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
2Department of Pathology, Duke University, Durham, NC

Chrysoula Kordella1*, Anastasiya Kazachenka2*, Eleftheria Lamprianidou1*, Emmanouela Zoulia1*, George Vrachiolias1*, Menelaos Konstantinos Papoutselis1*, Zoe Bezirgiannidou1*, Emmanouil Spanoudakis1*, Christiana Georgiou2*, Urszula Eksmond2*, George Kassiotis2,3* and Ioannis Kotsianidis, PhD4

11. Department of Hematology, University hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece, Alexandroupolis, Greece
22. Retroviral Immunology, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK, London, United Kingdom
33. Department of Medicine, Faculty of Medicine, Imperial College London W2 1PG, UK, London, United Kingdom
4Department of Hematology, University hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece, Alexandroupolis, Greece

David Muench, BS1, Kyle Ferchen, BS2*, Chinavenmeni S. Velu, PhD3,4*, Kith Pradhan, PhD5*, Kashish Chetal, MS6*, Clemencia Colmenares, PhD7*, Amit Verma, MD8, Nathan Salomonis, Ph.D.6* and H. Leighton Grimes, Ph.D.9

1Molecular and Developmental Biology Graduate Program, Cincinnati Children's Hospital Medical Center, Fort Wright, KY
2Department of Cancer Biology, University of Cincinnati, Cincinnati
3Cincinnati Children's Hosp. Med. Ctr., Cincinnati, OH
4Cincinnati Children's Hosp. Med. Ctr., Cincinnati
5Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
6Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7Lerner Research Institute, Cleveland Clinic, Cleveland, OH
8Albert Einstein College of Medicine-Montefiore Medical Center, Bronx, NY
9Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Yasunobu Nagata1*, Satoshi Narumi, MD, PhD2*, Yihong Guan1*, Bartlomiej P. Przychodzen1*, Cassandra M. Hirsch1*, Hideki Makishima, MD, PhD3, Hirohito Shima2*, Victor Pastor Loyola, MSc4*, Teodora Kuzmanovic, BA1*, Tomas Radivoyevitch, PhD5*, Vera Adema, PhD1*, Hassan Awada, MD1, Kenichi Yoshida, MD, PhD3*, Francesc Sole, PhD6, Babal K. Jha1*, Rabi Hanna, MD7, Thomas Laframboise, PhD8*, Seishi Ogawa, MD, PhD9, Mikkael A. Sekeres, MD, MS10, Marcin W. Wlodarski, MD, PhD4,11, Jorg Cammenga, MD12* and Jaroslaw P. Maciejewski1

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan
3Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
6MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
7Department of Pediatric Hematology Oncology and Bone Marrow Transplant, Cleveland Clinic, Cleveland, OH
8Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH
9Department of Pathology and Tumor Biology, Kyoto University, Sakyoku, Japan
10Leukemia Program, Department of Hematology and Medical Oncology,Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
11Hematology, St. Jude Children's Research Hospital, Memphis, TN
12Linköping University, Department of Hematology, Linköping, SWE

Louis Williams, MD, MBA1, Teodora Kuzmanovic, BA2*, Cassandra M. Hirsch2*, Bartlomiej P. Przychodzen2*, Yogenthiran Saunthararajah, MD3, Hassan Awada, MD2, Vera Adema, PhD2*, Amy C Graham, BS, MS2*, Tomas Radivoyevitch, PhD2*, Hetty E. Carraway, MD, MBA4,5,6, Aziz Nazha, MD4, Mikkael A. Sekeres, MD, MS7 and Jaroslaw P. Maciejewski8

1NYU, New York, NY
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Translational Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic Case Western Reserve Univ., Cleveland, OH
4Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH
5Taussig Cancer Institute, Cleveland Clinic, Leukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH
6Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
7Leukemia & Myeloid Disorders Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
8Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Teodora Kuzmanovic1*, Bhumika J. Patel, MD2, Yasunobu Nagata3*, Hassan Awada, MD4, Cassandra M. Hirsch3*, Bartlomiej P. Przychodzen1*, Srinivasa Reddy Sanikommu, MD5, Louis Williams, MD, MBA6, Sudipto Mukherjee, MD, PhD, MPH2, Anjali S. Advani, MD7, Aziz Nazha, MD8, Aaron T. Gerds, MD, MS9, Tomas Radivoyevitch, PhD3*, Hetty E. Carraway, MD, MBA7,10,11, Mikkael A. Sekeres, MD, MS12 and Jaroslaw P. Maciejewski3

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Fairview Park, OH
5Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium health, Charlotte, NC
6NYU, New York, NY
7Taussig Cancer Institute, Cleveland Clinic, Leukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH
8Cleveland Clinic, Avon Lake, OH
9Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
10Taussig Cancer Institute, Cleveland Clinic, Department of Hematology and Medical Oncology, Cleveland, OH
11Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
12Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Michele Kyncl, MSc1*, Lisa Bast, MSc2,3*, Lynette Henkel4*, Fabian Theis, PhD2,3*, Robert A.J. Oostendorp, PhD1*, Carsten Marr, PhD2,3* and Katharina S. Götze, MD1,5

1Department of Medicine III, Technical University of Munich, Munich, Germany
2Department of Mathematics, Technical University of Munich, Munich, Germany
3Institute of Computational Biology, Helmholtz Zentrum München–German Research Center for Environmental Health, Munich, Germany
4Institute of Microbiology, Technical University of Munich, Munich, Germany
5German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany

Wontak Kim*, Clifford Whatcott, PhD*, Adam Siddiqui-Jain, PhD*, Stephen Anthony, DO, David J. Bearss, PhD and Steven L. Warner, PhD

Tolero Pharmaceuticals, Inc., Lehi, UT

Alexey Aleshin, MD, MBA1, Marianne A Santaguida, PhD2*, Michael A Spinner, MD3, Jeffrey N Sanders3*, A Scott Patterson2*, Christos Gekas, PhD2*, Steven Schaffert, PhD2,3* and Peter L Greenberg, M.D.4

1Stanford University Cancer Center, Menlo Park, CA
2Notable Labs, Foster City, CA
3Stanford University, Stanford, CA
4Stanford University Cancer Center, Stanford, CA

*signifies non-member of ASH